Cargando…
Leptin signalling, obesity and prostate cancer: molecular and clinical perspective on the old dilemma
The prevalence of global obesity is increasing. Obesity is associated with general cancer-related morbidity and mortality and is a known risk factor for development of specific cancers. A recent large systematic review of 24 studies based on meta-analysis of 11,149 patients with prostate cancer show...
Autores principales: | Alshaker, Heba, Sacco, Keith, Alfraidi, Albandri, Muhammad, Aun, Winkler, Mathias, Pchejetski, Dmitri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742124/ https://www.ncbi.nlm.nih.gov/pubmed/26376613 |
Ejemplares similares
-
Histone deacetylases as new therapy targets for platinum-resistant epithelial ovarian cancer
por: Pchejetski, Dmitri, et al.
Publicado: (2015) -
Monocytes acquire prostate cancer specific chromatin conformations upon indirect co-culture with prostate cancer cells
por: Alshaker, Heba, et al.
Publicado: (2022) -
Transcriptome-Wide Effects of Sphingosine Kinases Knockdown in Metastatic Prostate and Breast Cancer Cells: Implications for Therapeutic Targeting
por: Alshaker, Heba, et al.
Publicado: (2019) -
Everolimus (RAD001) sensitizes prostate cancer cells to docetaxel by down-regulation of HIF-1α and sphingosine kinase 1
por: Alshaker, Heba, et al.
Publicado: (2016) -
Sphingosine Kinase 1 in Breast Cancer—A New Molecular Marker and a Therapy Target
por: Alshaker, Heba, et al.
Publicado: (2020)